Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CTC is a globally recognized sugarcane biotechnology company focused on research, development, and commercialization of genetically improved sugarcane varieties using advanced breeding and biotech methods. It operates the largest sugarcane germplasm bank in the world and has a strong R&D infrastructure, including state-of-the-art laboratories and a global network of research hubs. The company's innovations are aimed at increasing sugarcane productivity for the sugar-energy sector, which indirectly supports biofuels and renewable energy, relevant to public health and sustainability goals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centro de Tecnologia Canavieira.